Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

To understand the full scope of this medication -- its effectiveness, risks, and who stands to benefit the most -- ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Collaborative drug therapy management (CDTM) is practiced throughout the United States and is officially recognized in 25 states and by the federal government (armed forces and Veterans Affairs).

Patients assigned to the drug saw a mean decrease in Vitiligo Area ... differed little from that seen with ultraviolet light therapy alone in a study conducted more than 20 years ago.

There is no approved treatment for high Lp(a), but five drugs are in development ... lowering you'd want to see with a new therapy and comparable to the other agents in development.” ...

Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab) combination has received approval from the US Food and Drug Administration (FDA ... of the Phase III CodeBreaK 300 trial which showed the ...

Image credit: Shutterstock / Tamakhin Mykhailo. The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance ...